Cargando…
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
PURPOSE: The use of electronic patient-reported outcome (ePRO) data in routine care has been tied to direct patient benefits such as improved quality of care and symptom control and even overall survival. The modes of action behind such benefits are seldom described in detail. Here, we describe the...
Autores principales: | da Silva Lopes, André Manuel, Colomer-Lahiguera, Sara, Darnac, Célia, Giacomini, Stellio, Bugeia, Sébastien, Gutknecht, Garance, Spurrier-Bernard, Gilliosa, Aedo-Lopez, Veronica, Mederos, Nuria, Latifyan, Sofiya, Addedo, Alfredo, Michielin, Olivier, Eicher, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363070/ https://www.ncbi.nlm.nih.gov/pubmed/37480546 http://dx.doi.org/10.1007/s00520-023-07934-w |
Ejemplares similares
-
Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial
por: da Silva Lopes, André Manuel, et al.
Publicado: (2023) -
CN31 Oncology nurses' experience in German and French-speaking Switzerland during the COVID-19 pandemic
por: Eicher, M., et al.
Publicado: (2020) -
Targeting immune checkpoints in breast cancer: an update of early results
por: Solinas, Cinzia, et al.
Publicado: (2017) -
Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review
por: Colomer-Lahiguera, Sara, et al.
Publicado: (2020) -
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events
por: Coukos, Alexander, et al.
Publicado: (2022)